Navigation Links
Genomas Awarded US Patent for its PhyzioGenomics Platform Technology to Predict Treatment Responses
Date:9/13/2010

HARTFORD, Conn., Sept. 13 /PRNewswire/ -- Genomas®, a biomedical company advancing DNA-Guided Medicine, has been awarded US Patent 7,747,392, entitled Physiogenomic Method for Predicting Clinical Outcomes of Treatment in Patients by the US Patent and Trademark Office.

Andreas Windemuth, Ph.D., Chief Technology Officer and co-inventor in the patent stated: "The PhyzioGenomics Technology has been successfully applied to several psychiatric and diabetes drugs and to brain imaging. The technology correlates genotypes and phenotypes in patient populations to discover clinically functional variability. The PhyzioGenomics Technology integrates a biomedical engineering systems approach with genome probes and nano-arrays."

Research on the PhyzioGenomics Technology has been published in the renowned journals Annals of Biomedical Engineering, Biomedical Engineering Handbook, Clinica Chimica Acta, Clinics in Laboratory Medicine, Molecular Psychiatry, Muscle & Nerve, Personalized Medicine, Pharmacogenomics, and Schizophrenia Research.

Gualberto Ruano, M.D., Ph.D., President of Genomas and co-inventor commented: "This fundamental patent covers also the configuration of our products and pipeline, the PhyzioTypeTM Systems. This is a landmark achievement for Genomas and allows us freedom to operate in our industry sector. In an otherwise crowded genomics landscape, and in the presence of an ever more stringent yardstick on novelty versus prior art, this patent significantly increases the value of our intellectual property portfolio and differentiates our proprietary PhyzioType products."

Filed in 2006, US Patent 7,747,392 comprises 23 methods claims and 384 polymorphic DNA sequences representative of 222 key cardiometabolic and neuroendocrine genes. Beyond this patent, the Intellectual Property portfolio of Genomas encompasses 5 patent applications, 2 trademarks, and a copyright on the company's clinical informatics system.

ABOUT GENOMAS

Genomas is a biomedical company advancing DNA-Guided Medicine and personalized healthcare. The company develops revolutionary PhyzioType™ Systems for DNA-guided management and prescription of drugs used to treat mental illness and diabetes. PhyzioType Systems provide physicians with an unprecedented capability to select for each patient the safest and most effective drug to achieve treatment goals and enhance patient compliance.

The company's clinical pharmacogenetic tests and consultation service are provided through its Laboratory of Personalized Health, an accredited and licensed high-complexity molecular diagnostic center and its Personalized Health Portal, a medical informatics interface for clinician decision support. Visit www.genomas.com for more information.


'/>"/>
SOURCE Genomas
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Genomas Awarded $1.4 Million NIH SBIR Grant to Develop MRI+DNA Guided Biomarker System for Mental Illness
2. Genomas and Institute of Living Among Organizers of Pharmacogenetics Symposium at 2009 Annual Meeting of the American Psychiatric Association
3. Cardiovascular Side Effects of Pioglitazone and Rosiglitazone Linked to Vascular and Energy Pathways by Genomas Clinical Study
4. Genomas to Present at Life Sciences & Healthcare Venture Summit
5. Connecticut State Medical Society and Genomas Co-Sponsor Forum on DNA-Guided Medicine and the Path to Personalized Health Care
6. Elusys Awarded Additional $40.6 Million Under Existing U.S. Government Contract to Fund Advanced Development of Anthim, a New Treatment for Anthrax
7. Isolux Corsan Awarded a Contract for the Construction of an Ethanol Plant in Colombia
8. Laser pioneer Federico Capasso awarded Berthold Leibinger Zukunftspreis
9. San Diego Region Awarded $4 Million Workforce Development Grant to Support Expanding Biofuels Industry
10. Flad Architects Awarded Livermore Valley Open Campus Master Plan
11. Colorado State University student awarded top student prize in laser research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology ... drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription ... is able to cross the cell membrane and bind intracellular STAT3 and inhibit ...
(Date:10/10/2017)... International research firm Parks Associates announced today that ... TMA 2017 Annual Meeting , October 11 in Scottsdale, ... security market and how smart safety and security products impact the competitive ... Parks Associates: Smart Home Devices: Main ... "The residential security market has experienced continued ...
(Date:10/9/2017)... Jupiter, FL (PRWEB) , ... October 09, 2017 , ... ... episode, scheduled to broadcast first quarter 2018. American Farmer airs Tuesdays at 8:30aET on ... Agriculture industry is faced with the challenge of how to continue to feed a ...
(Date:10/7/2017)... ... October 06, 2017 , ... Phase ... metagenome deconvolution product, featuring the first commercially available Hi-C kit. Researchers can ... Hi-C metagenome deconvolution using their own facilities, supplementing the company’s full-service ProxiMeta ...
Breaking Biology Technology:
(Date:4/13/2017)... MONICA, Calif. , April 13, 2017 ... New York will feature emerging and evolving ... Summits. Both Innovation Summits will run alongside the expo ... of speaker sessions, panels and demonstrations focused on trending ... coast,s largest advanced design and manufacturing event will take ...
(Date:4/11/2017)... BROOKLYN, N.Y. , April 11, 2017 /PRNewswire-USNewswire/ ... identical fingerprints, but researchers at the New York ... University College of Engineering have found that partial ... fingerprint-based security systems used in mobile phones and ... previously thought. The vulnerability lies in ...
(Date:4/5/2017)... 5, 2017 Today HYPR Corp. , ... server component of the HYPR platform is officially ... end-to-end security architecture that empowers biometric authentication across Fortune ... already secured over 15 million users across the financial ... connected home product suites and physical access represent a ...
Breaking Biology News(10 mins):